Table 2. The genotypic and allelic distribution of EL gene polymorphisms in CAD and control subjects.
| SNPs | CAD [n(%)] | Controls [n(%)] | X2 | P |
|---|---|---|---|---|
| 2037 T/C (rs3744843) | ||||
| TT | 444 (62.89%) | 167 (53.02%) | 9.060 | 0.011 |
| TC | 234 (33.14%) | 130 (41.27%) | ||
| CC | 28 (3.97%) | 18 (5.71%) | ||
| T | 1122 (79.46%) | 464 (73.65%) | 8.481 | 0.004 |
| C | 290 (20.54%) | 166 (26.35%) | ||
| 2237 G/A (rs3744841) | ||||
| GG | 255 (36.12%) | 138 (43.81%) | 5.632 | 0.060 |
| GA | 349 (49.43%) | 134 (42.54%) | ||
| AA | 102 (14.45%) | 43 (13.65%) | ||
| G | 859 (60.84%) | 410 (65.08%) | 3.335 | 0.075 |
| A | 553 (39.16%) | 220 (34.92%) |
SNPs, single nucleotide polymorphisms; CAD, coronary artery disease; P values were calculated by X2 test.